Short answer: EU buyers of an aesthetic light device that falls under the Medical Device Regulation (MDR) should ask how the supplier manages EUDAMED records, rather than assume a brochure’s CE symbol tells the whole traceability story. The European Commission announced that four EUDAMED modules became mandatory to use from May 28, 2026: actor registration, UDI/device registration, notified bodies and certificates, and market surveillance. This is a database implementation milestone, not an EU endorsement of every laser, IPL or LED product.
What changed, and why
The Commission’s November 27, 2025 announcement says a formal decision on the functionality of the first four modules triggered a six-month transition period. The effective date it identifies is May 28, 2026. For a procurement team, the practical point is that economic-operator and device information can be handled through more structured records where the relevant MDR obligations apply. A buyer should ask the legal manufacturer and EU economic operator which entries are required for the exact device, and how the identifier on the delivered unit maps to those records.
UDI means unique device identification. The Commission lists UDI/device registration separately from actor registration, so checking an operator alone is not the same as matching a particular device. The notified-body and certificate module can help document a conformity-assessment trail where such involvement is required. Market surveillance is a separate module, not a certification service for sellers. None of these labels means a device has been clinically proven for every treatment advertised by a reseller.
A useful buyer workflow
Begin with the model, legal manufacturer, EU representative or importer as applicable, intended purpose, class and declaration of conformity. Ask the supplier for the relevant identifiers and certificates, then compare the names, scope and configuration across those documents. If a certificate is cited, make sure the issuing notified body and certificate scope actually correspond to the product and activities claimed. A document for another model, for a quality system alone or for an unrelated product family does not settle the status of the unit being purchased.
Record the result in the purchasing file along with instructions for use, labels, service arrangements and any limitations on proposed claims. If the device is for non-medical aesthetic purposes yet within Annex XVI, seek competent EU regulatory advice on the applicable rules. If it is outside that scope or subject to a different regime, avoid forcing it into an MDR narrative merely because it emits light. The regulatory status of a laser for hair removal, an IPL platform, an LED mask and an RF device cannot be inferred from technology shorthand alone.
Limits and review
The Commission’s announcement lists modules and the mandatory-use date; it does not give a product-specific verdict or explain every transitional exception. The broader MDR, implementing acts and current Commission instructions govern detailed obligations. Buyers and manufacturers should check them with qualified EU specialists, particularly for legacy or mixed-purpose products. This article makes no claim that TUOKE sells a particular optical device, has a EUDAMED entry or holds a CE certificate. Database visibility is useful evidence to inspect, not a substitute for technical and clinical due diligence.
See the optical aesthetic equipment insights archive for more jurisdiction-specific purchasing questions.
Source
- European Commission, first four EUDAMED modules mandatory from May 28, 2026, published November 27, 2025; reviewed October 13, 2026.